You're reading the free version. Trader adds the live tape and alerts.
Start tracking
AMLX Sale Disclosure
Frates James M · SEC Form 4 · Filed Nov 12, 2026
Sale
Calculated transaction value
$222.98K
Frates James M Chief Financial Officer
AMLX
Transaction date
Nov 10, 2026
Public filing date
Nov 12, 2026
Filing lag
Filed 2 days later
AMLX daily price context
Close on/before transaction
$30.91
Nov 10, 2026
First close after public filing
--
Unavailable
30-day return after filing
--
Through Unavailable
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 7,200 shares @ $30.97
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001193125-26-458247
Filing cohort
Transactions in this filing
Showing 8 of 8
Trades
8
Issuers
1
Estimated value
$1.48M
Buys / sales
0 / 4
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Amylyx Pharmaceuticals, Inc. AMLX | Exercise | Nov 10, 2026 | $137.6K |
| Amylyx Pharmaceuticals, Inc. AMLX | Sale | Nov 10, 2026 | $388.11K |
| Amylyx Pharmaceuticals, Inc. AMLX Current | Sale | Nov 10, 2026 | $222.98K |
| Amylyx Pharmaceuticals, Inc. AMLX | Exercise | Nov 10, 2026 | $0 |
| Amylyx Pharmaceuticals, Inc. AMLX | Sale | Nov 9, 2026 | $370.36K |
| Amylyx Pharmaceuticals, Inc. AMLX | Exercise | Nov 9, 2026 | $137.6K |
| Amylyx Pharmaceuticals, Inc. AMLX | Sale | Nov 9, 2026 | $226.29K |
| Amylyx Pharmaceuticals, Inc. AMLX | Exercise | Nov 9, 2026 | $0 |